Abiopharma

Hollywood Mark 🟡 adjusted position in 176.9K shares (4 derivative) of Zymeworks Inc. (ZYME) at $23.16 ($1.8M) Transaction Date: Jan 12, 2026 | Filing ID: 011885

BENKOWITZ MICHAEL 🟡 adjusted position in 22.5K shares (2 derivative) of UNITED THERAPEUTICS Corp (UTHR) at $479.51 ($16.5M) Transaction Date: Jan 12, 2026 | Filing ID: 000005

New Form SCHEDULE 13D/A - Foghorn Therapeutics Inc. Filed: 2026-01-13 AccNo: 0001193125-26-011881 Size: 32 KB

New Form 3 - Zymeworks Inc. Filed: 2026-01-13 AccNo: 0001193125-26-011875 Size: 23 KB

Director Kornberg Roger D. 🟢 acquired 24.6K shares (1 derivative) of Cocrystal Pharma, Inc. (COCP) at $1.10 Transaction Date: Jan 09, 2026 | Filing ID: 000263

Tan Kevin 🟡 adjusted position in 5.7K shares (1 derivative) of Solid Biosciences Inc. (SLDB) at $5.27 Transaction Date: Jan 09, 2026 | Filing ID: 011873

📋 Tan Kevin (Officer) plans to sell 6K shares of Solid Biosciences Inc. (at $5.27 each, total $30K) Filed: Jan 13, 2026 | ID: 011869

BURNETT JOSEPH 🟡 adjusted position in 20.0K shares (1 derivative) of ClearPoint Neuro, Inc. (CLPT) at $16.12 Transaction Date: Jan 09, 2026 | Filing ID: 011866

New Form 3 - Syra Health Corp Filed: 2026-01-13 AccNo: 0001493152-26-002071 Size: 2 KB

Stout Stephen 🟡 adjusted position in 347.2K shares (1 derivative) of Shattuck Labs, Inc. (STTK) at $4.75 ($1.7M) Transaction Date: Jan 10, 2026 | Filing ID: 011860